Debjit Chattopadhyay
Stock Analyst at Guggenheim
(4.66)
# 193
Out of 5,036 analysts
107
Total ratings
59.18%
Success rate
28.88%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Debjit Chattopadhyay
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LXEO Lexeo Therapeutics | Initiates: Buy | $30 | $9.60 | +212.50% | 1 | Oct 15, 2025 | |
| CNTA Centessa Pharmaceuticals | Reiterates: Buy | $28 | $22.74 | +23.13% | 7 | Oct 6, 2025 | |
| QURE uniQure | Maintains: Buy | $28 → $95 | $63.07 | +50.63% | 7 | Sep 25, 2025 | |
| PEPG PepGen | Reiterates: Buy | $6 | $4.88 | +22.95% | 2 | Sep 24, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $90 → $92 | $71.64 | +28.42% | 6 | Sep 23, 2025 | |
| RZLT Rezolute | Reiterates: Buy | $15 | $8.86 | +69.30% | 3 | Sep 22, 2025 | |
| SRPT Sarepta Therapeutics | Reiterates: Buy | $22 | $23.35 | -5.78% | 6 | Sep 15, 2025 | |
| MAZE Maze Therapeutics | Maintains: Buy | $19 → $34 | $29.52 | +15.18% | 3 | Sep 15, 2025 | |
| SLNO Soleno Therapeutics | Reiterates: Buy | $106 | $67.13 | +57.90% | 5 | Aug 27, 2025 | |
| PASG Passage Bio | Maintains: Buy | $40 → $10 | $8.75 | +14.29% | 3 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $14 | $26.97 | -48.09% | 3 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $101 → $106 | $53.81 | +96.99% | 4 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $558 → $546 | $426.27 | +28.09% | 8 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $64 | $34.19 | +87.19% | 3 | Jun 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $16.75 | +198.51% | 5 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $189 | $190.78 | -0.93% | 4 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $55 | $29.89 | +84.01% | 3 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $5.59 | +222.00% | 3 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $15.86 | +7.19% | 2 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $8.47 | +77.10% | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Neutral | n/a | $72.32 | - | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $6.99 | +171.82% | 2 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $4.97 | +342.66% | 1 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $36.48 | -17.76% | 1 | Jan 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $29 | $1.26 | +2,201.59% | 1 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $474.00 | - | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $5.15 | +443.69% | 1 | Dec 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $20 | $7.85 | +154.78% | 2 | Dec 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $270 → $123 | $31.43 | +291.35% | 8 | Aug 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $54 | $17.93 | +201.17% | 3 | Jul 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $60 | $1.49 | +3,926.85% | 3 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $43.45 | - | 3 | Jun 26, 2017 |
Lexeo Therapeutics
Oct 15, 2025
Initiates: Buy
Price Target: $30
Current: $9.60
Upside: +212.50%
Centessa Pharmaceuticals
Oct 6, 2025
Reiterates: Buy
Price Target: $28
Current: $22.74
Upside: +23.13%
uniQure
Sep 25, 2025
Maintains: Buy
Price Target: $28 → $95
Current: $63.07
Upside: +50.63%
PepGen
Sep 24, 2025
Reiterates: Buy
Price Target: $6
Current: $4.88
Upside: +22.95%
Ionis Pharmaceuticals
Sep 23, 2025
Maintains: Buy
Price Target: $90 → $92
Current: $71.64
Upside: +28.42%
Rezolute
Sep 22, 2025
Reiterates: Buy
Price Target: $15
Current: $8.86
Upside: +69.30%
Sarepta Therapeutics
Sep 15, 2025
Reiterates: Buy
Price Target: $22
Current: $23.35
Upside: -5.78%
Maze Therapeutics
Sep 15, 2025
Maintains: Buy
Price Target: $19 → $34
Current: $29.52
Upside: +15.18%
Soleno Therapeutics
Aug 27, 2025
Reiterates: Buy
Price Target: $106
Current: $67.13
Upside: +57.90%
Passage Bio
Aug 14, 2025
Maintains: Buy
Price Target: $40 → $10
Current: $8.75
Upside: +14.29%
Aug 13, 2025
Maintains: Buy
Price Target: $45 → $14
Current: $26.97
Upside: -48.09%
Aug 6, 2025
Maintains: Buy
Price Target: $101 → $106
Current: $53.81
Upside: +96.99%
Aug 6, 2025
Maintains: Buy
Price Target: $558 → $546
Current: $426.27
Upside: +28.09%
Jun 20, 2025
Reiterates: Buy
Price Target: $64
Current: $34.19
Upside: +87.19%
Jun 18, 2025
Reiterates: Buy
Price Target: $50
Current: $16.75
Upside: +198.51%
May 7, 2025
Maintains: Buy
Price Target: $195 → $189
Current: $190.78
Upside: -0.93%
May 7, 2025
Maintains: Buy
Price Target: $78 → $55
Current: $29.89
Upside: +84.01%
Dec 3, 2024
Reiterates: Buy
Price Target: $18
Current: $5.59
Upside: +222.00%
Dec 3, 2024
Reiterates: Buy
Price Target: $17
Current: $15.86
Upside: +7.19%
Nov 7, 2024
Maintains: Buy
Price Target: $13 → $15
Current: $8.47
Upside: +77.10%
Jun 28, 2024
Assumes: Neutral
Price Target: n/a
Current: $72.32
Upside: -
Apr 30, 2024
Initiates: Buy
Price Target: $19
Current: $6.99
Upside: +171.82%
Mar 26, 2024
Initiates: Buy
Price Target: $22
Current: $4.97
Upside: +342.66%
Jan 18, 2024
Initiates: Buy
Price Target: $30
Current: $36.48
Upside: -17.76%
Nov 21, 2022
Maintains: Buy
Price Target: $43 → $29
Current: $1.26
Upside: +2,201.59%
Jun 27, 2022
Downgrades: Neutral
Price Target: n/a
Current: $474.00
Upside: -
Dec 16, 2021
Initiates: Buy
Price Target: $28
Current: $5.15
Upside: +443.69%
Dec 15, 2020
Assumes: Buy
Price Target: $20
Current: $7.85
Upside: +154.78%
Aug 24, 2020
Downgrades: Neutral
Price Target: $270 → $123
Current: $31.43
Upside: +291.35%
Jul 9, 2020
Maintains: Buy
Price Target: $60 → $54
Current: $17.93
Upside: +201.17%
Dec 3, 2019
Downgrades: Neutral
Price Target: $60
Current: $1.49
Upside: +3,926.85%
Jun 26, 2017
Downgrades: Neutral
Price Target: n/a
Current: $43.45
Upside: -